Ibrutinib As Part of Risk-Stratified Treatment for Post-Transplant Lymphoproliferative Disorder: the Phase 2 TIDaL Trial
Sridhar Chaganti,Shanna Maycock,Graham Mcilroy,Aimee Jackson,Rebecca Bishop, Sarah Johnson,Edward Kanfer,Shireen Kassam,Kate Cwynarski,David Wrench,Arvind Arumainathan,Christopher P. Fox,Rod Johnson,Pam Mckay,Shankara Paneesha,Clare Rowntree,Constantine Balotis,Graham P. Collins,Andrew Davies,Josh Wright, Sarah Burns, Arian Laurence,Keith Wheatley,Tobias Menne Blood（2024）
AI 理解论文
溯源树
样例
